GEHC GE HealthCare

FY2025 10-K
Filed: Feb 4, 2026
Health Care
X-Ray Apparatus & Tubes & Related Irradiation ApparatusSEC EDGAR

GE HealthCare (GEHC) filed its fiscal year 2025 10-K annual report with the SEC on Feb 4, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business: global healthcare solutions provider delivering advanced medical tech, diagnostics, AI, cloud, and software for personalized patient care
  • New emphasis on AI-enabled software solutions upgradeable through equipment lifecycle, enhancing multi-site healthcare network operations
+3 more insights

Management Discussion & Analysis

  • Revenue $20,625M, up 4.8% YoY; Product sales $13,661M (+4.5%, +$586M), Services $6,964M (+5.6%, +$368M)
  • Operating income $2,763M (13.4% margin vs 13.3%), net income $2,084M (10.1% margin, flat YoY)
+3 more insights

Risk Factors

  • US tariffs on global imports in 2025 materially reduced profitability and cash flows, with ongoing risk of additional tariffs impacting financial results
  • Russia-Ukraine conflict and resulting US, EU sanctions increased costs and restricted supply to Russian customers, with uncertain license approvals from US authorities
+3 more insights

Financial Summary
XBRL

Revenue

$20.6B

Net Income

$2.1B

Gross Margin

40.0%

Operating Margin

13.4%

Net Margin

10.1%

ROE

20.1%

Total Assets

$36.9B

EPS (Diluted)

$4.55

Operating Cash Flow

$2.0B

Source: XBRL data from GE HealthCare FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on GE HealthCare

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available